Dexcom Inc. Stock
€56.70
Your prediction
Dexcom Inc. Stock
Pros and Cons of Dexcom Inc. in the next few years
Pros
Cons
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | 0.020% | -6.974% | 3.355% | -12.623% | -1.099% | -44.060% | -24.199% |
| Baxter International | -1.880% | -4.195% | -0.596% | -50.502% | -3.842% | -56.179% | -75.843% |
| Teleflex Inc. | -1.060% | -4.455% | 8.427% | -21.545% | -5.392% | -54.048% | -72.429% |
| Dentsply Sirona Inc. | -4.040% | -10.483% | -4.722% | -26.918% | 7.299% | -70.363% | -80.422% |
Comments
News
2 Growth Stocks to Hold for the Next Decade
Over the past year, Intuitive Surgical (NASDAQ: ISRG) and DexCom (NASDAQ: DXCM) have faced headwinds, and have lagged the stock market as a result. Shares of the former are down 13% over the
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars
Many pharmaceutical companies are looking to develop and market the now highly popular GLP-1 drugs, which help treat diabetes, help patients lose weight, and reduce their risk of a range of
DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price?
It's been a tough year for DexCom (NASDAQ: DXCM), whose stock price is down 25% since the start of 2025. It's a surprising performance, given that the overall stock market has been doing well; you


